Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2025-12-27 @ 6:36 PM
Study NCT ID:
NCT04869592
Status:
UNKNOWN
Last Update Posted:
2023-02-02
First Post:
2021-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19
Sponsor:
National Vaccine and Serum Institute, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-24
First Submit QC Date:
None
Study First Post Date:
2021-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-31
Last Update Post Date:
2023-02-02
Last Update Post Date Type:
ACTUAL